No BP agents prolong kidney disease survival


  • The BMJ
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

No blood pressure lowering agents used either alone or in combination prolong survival in adults with diabetes and kidney disease, a meta-analysis published in the Lancet has found.1

Researchers analysed 157 studies comparing blood pressure lowering agents in a total of 43 256 patients with dia...